Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean

BACKGROUND: RotaTeq™ (RV5; Merck & Co. Inc., USA) and Rotarix™ (RV1, GlaxoSmithKline, Belgium) vaccines, developed to prevent rotavirus diarrhea in children under five years old, were both introduced into national immunization programs in 2006. As many countries in Latin America and the Caribbea...

Descripción completa

Detalles Bibliográficos
Autores principales: Velázquez, Raúl F., Linhares, Alexandre C., Muñoz, Sergio, Seron, Pamela, Lorca, Pedro, DeAntonio, Rodrigo, Ortega-Barria, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237165/
https://www.ncbi.nlm.nih.gov/pubmed/28086819
http://dx.doi.org/10.1186/s12887-016-0771-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237165/
https://www.ncbi.nlm.nih.gov/pubmed/28086819
http://dx.doi.org/10.1186/s12887-016-0771-y

Ejemplares similares